HopeStage
Back to all studies
CompletedNCT00191633

Atomoxetine and the link between ADHD symptoms and daily functioning in children

About this titleRead the official source — NCT00191633
Medication studyAges 6–11Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 11 years. Other eligibility criteria applied.

Listed locations
Calgary and 18 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2005
Recruitment status
Completed
Enrollment listed in the registry
200
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 6 Years to 11 Years
Official registry ID
NCT00191633
Official title
Show the full official title

A 3 Month Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder; Symptomatic and Functional Outcomes.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Calgary · Edmonton · Abbotsford British Columbia

16 more locations
  • Burnaby
  • Kelowna
  • Langley
  • Vancouver
  • Winnipeg
  • Moncton
  • Saint John
  • Halifax
  • Markham
  • Niagara Falls
  • Oshawa
  • Pickering
  • Toronto
  • Whitby
  • Summerside
  • Saskatoon

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Atomoxetine.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 11 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies